Strategic Consultant to Market Access and HEOR projects
Market Access Strategy
- Developing or/ and supporting your market access strategy including:
- HTA and market access landscape assessments
- Strategic review and gap analysis of HTA submission plans and dossiers, of clinical development, and HEOR plans
- External experts insights
Integrated Evidence Planning
- Strategic recommendations for global evidence planning by integrating the patient’s voice, real world evidence and value based pricing in your road-map
- Chairing, facilitating or developing external advisory boards and internal multidisciplinary workshops
Value Communication
- Critically reviewing or preparing product value propositions and value messages
- Developing and leading interactive training sessions and workshops in international HTA, market access, real world evidence or patient voice
Why Jeanni
Over 25 years of experience in guiding and critically reviewing HEOR and real world evidence projects and developing market access strategies for key markets
Combines good clinical, patient reported outcomes and economic knowledge into strategic advice to provide the big picture
Ensures the right questions are addressed and that the project goals remain on target
Proven analytical and problem-solving skills with a creative mind
A solid understanding of different stakeholders’ expectations and HTA requirements
Large network (with payer-)advisors throughout Europe
Organized and delivered training and workshops over the last 25 years to a variety of stakeholders: patient advocacy organization, health insurance companies, cross-functional teams in pharma etc.